FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| Fidarestat, 136087-85-9, Fidarestat Intermediate 105300-40-1, stock 651.9g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply. |
| Fidarestat, 136087-85-9, Fidarestat Intermediate 116925-74-7, stock 492.1g, white powder, assay by HPLC 99.5%, HNMR, LCMS we supply. |
| Fidarestat, 136087-85-9, Fidarestat Intermediate /, stock 796.5g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
| Fidarestat, 136087-85-9, Fidarestat Intermediate /, stock 521.7g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| Fidarestat, 136087-85-9, Fidarestat Intermediate /, stock 585.2g, white powder, assay by HPLC 99.2%, HNMR, LCMS we supply. |
| Fidarestat, 136087-85-9, Fidarestat Intermediate /, stock 500.5g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
